RTN4RL1
Basic information
Region (hg38): 17:1934677-2025334
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RTN4RL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 13 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 1 | 4 |
Variants in RTN4RL1
This is a list of pathogenic ClinVar variants found in the RTN4RL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-1936546-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
17-1936605-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
17-1936638-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
17-1936654-A-T | not specified | Uncertain significance (Oct 05, 2022) | ||
17-1936669-G-T | not specified | Uncertain significance (Jan 19, 2024) | ||
17-1936687-C-T | not specified | Uncertain significance (Jun 28, 2022) | ||
17-1936748-G-T | not specified | Uncertain significance (Sep 27, 2021) | ||
17-1936766-C-T | Benign (Feb 20, 2018) | |||
17-1936767-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
17-1936853-C-A | not specified | Uncertain significance (Dec 21, 2022) | ||
17-1936899-G-A | Benign (Nov 20, 2017) | |||
17-1936918-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
17-1936932-C-T | not specified | Uncertain significance (Mar 16, 2024) | ||
17-1936960-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
17-1936988-G-A | Likely benign (May 01, 2022) | |||
17-1937009-C-A | not specified | Uncertain significance (Apr 07, 2022) | ||
17-1937034-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
17-1937168-G-A | Benign (Feb 20, 2018) | |||
17-1937383-C-T | Benign (Jan 05, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RTN4RL1 | protein_coding | protein_coding | ENST00000331238 | 2 | 90669 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.960 | 0.0397 | 124586 | 0 | 1 | 124587 | 0.00000401 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.47 | 212 | 281 | 0.753 | 0.0000190 | 2813 |
Missense in Polyphen | 59 | 111.98 | 0.52686 | 1212 | ||
Synonymous | -0.509 | 148 | 140 | 1.05 | 0.0000106 | 940 |
Loss of Function | 2.94 | 0 | 10.1 | 0.00 | 4.29e-7 | 119 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cell surface receptor. Plays a functionally redundant role in postnatal brain development and in regulating axon regeneration in the adult central nervous system. Contributes to normal axon migration across the brain midline and normal formation of the corpus callosum. Protects motoneurons against apoptosis; protection against apoptosis is probably mediated by MAG. Plays a role in inhibiting neurite outgrowth and axon regeneration via its binding to neuronal chondroitin sulfate proteoglycans. Binds heparin (By similarity). Like other family members, plays a role in restricting the number dendritic spines and the number of synapses that are formed during brain development (PubMed:22325200). Signaling mediates activation of Rho and downstream reorganization of the actin cytoskeleton (PubMed:22325200). {ECO:0000250|UniProtKB:Q8K0S5, ECO:0000269|PubMed:22325200}.;
- Pathway
- Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.0741
- rvis_EVS
- 0.4
- rvis_percentile_EVS
- 76.36
Haploinsufficiency Scores
- pHI
- 0.544
- hipred
- N
- hipred_score
- 0.498
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.214
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rtn4rl1
- Phenotype
- liver/biliary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- negative regulation of neuron projection development;corpus callosum development;axon regeneration;negative regulation of axon regeneration
- Cellular component
- extracellular region;extracellular space;plasma membrane;external side of plasma membrane;cell surface;extracellular matrix;cell projection;perikaryon;membrane raft;anchored component of plasma membrane;extracellular exosome
- Molecular function
- protein binding;heparin binding;chondroitin sulfate binding;signaling receptor activity